APA (7th ed.) Citation

Kawczak, P., & Bączek, T. (2026). Molecular Profiling and Targeted Therapeutic Strategies in Breast Cancer: Clinical Integration of HER2, CDK4/6, and PI3K Inhibition with Trastuzumab, Abemaciclib and Alpelisib. Journal of Clinical Medicine, 15(10), 3715. https://doi.org/10.3390/jcm15103715

Chicago Style (17th ed.) Citation

Kawczak, Piotr, and Tomasz Bączek. "Molecular Profiling and Targeted Therapeutic Strategies in Breast Cancer: Clinical Integration of HER2, CDK4/6, and PI3K Inhibition with Trastuzumab, Abemaciclib and Alpelisib." Journal of Clinical Medicine 15, no. 10 (2026): 3715. https://doi.org/10.3390/jcm15103715.

MLA (9th ed.) Citation

Kawczak, Piotr, and Tomasz Bączek. "Molecular Profiling and Targeted Therapeutic Strategies in Breast Cancer: Clinical Integration of HER2, CDK4/6, and PI3K Inhibition with Trastuzumab, Abemaciclib and Alpelisib." Journal of Clinical Medicine, vol. 15, no. 10, 2026, p. 3715, https://doi.org/10.3390/jcm15103715.